INTERVENTIONS:

MAIN OUTCOME MEASURES:

Patients completed posttreatment SNOT-20 and SF-36 surveys, which were compared for changes in sinonasal symptoms and QOL measures.

RESULTS:

Eleven patients completed the protocol. No adverse events were observed. There were trends toward improvement in most elements of the SNOT-20, whereas "need to blow nose" (P=.002), "runny nose" (P=.04), "reduced ability to concentrate" (P=.005), and "feeling frustrated, restless, or irritable" (P=.046) were statistically significant. In the SF-36, role physical (P=.01), vitality (P=.04), and social functioning (P=.008) were significantly improved.

CONCLUSIONS:

Preliminary data suggest that an integrated approach of traditional Western medicine with IEWM is safe and may improve symptoms and QOL for patients with recalcitrant CRS. Future randomized controlled trials are needed to validate the effects of IEWM and clarify its role in the treatment of CRS.